AVIVAGEN (formerly Chemaphor) Featured on Business Television (BTV)

(via Thenewswire.ca)

Avivagen Inc. - V.VIV:CDX

 

Ottawa, Ontario, May 29, 2012 - Avivagen Inc. (formerly Chemaphor Inc.; TSXV: CFR) (the "Company") announces that the Company was featured on Business Television (BTV) on May 26 and May 27, 2012, through segments on BNN and Fox Business News, among others. The segment highlighted Avivagen's recently launched supplement for companion animals. BTV is a half-hour weekly business news program that profiles emerging publicly traded companies across Canada and the U.S.
The Company was featured on BTV on the following channels:
In Canada:
-BNN - Saturday, May 26 @ 8:00pm EST & Sunday, May 27 @ 9:30am EST
-Bell Express Vu - Saturday, May 26 @ 8:00pm EST & Sunday, May 27 @ 9:30am EST
In the U.S.:
-Fox Business News - Sunday, May 27 @ 5:00pm EST
-America One - Saturday, May 26 @ 10:00am EST (www.americaone.com)
-Biz Television Network - Saturday, May 26 @ 1:30pm; Sunday, May 27 @ 1:30pm;
Wednesday, May 30 @7pm; Thursday, May 31 @ 10:30am; and Friday, June 1 @ 6:30pm EST
(www.biztv.com)
A link to the feature will be available on the Company's website (www.chemaphor.com) and is available here:
-http://www.b-tv.com/features/watch-now.html?clip=CEOChemaphorMay12.wm v
About Avivagen (formerly Chemaphor)
Avivagen, a wellness company, is committed to developing and delivering products for animals and humans to assist in optimizing health and daily quality of life. Avivagen is advancing product candidates for the food animal market, companion animal market and various potential human applications. More information can be found at www.chemaphor.com.
This news release and the video referred to herein include certain forward-looking statements that are based upon current expectations, which involve risks and uncertainties associated with the business of Avivagen Inc. and the environment in which its businesses operates. Any statements contained in this release or in the video referred to herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions "will", "anticipate", "believe", "plan", "estimate", "expect", "intend", and similar expressions. The forward-looking statements reflect the current expectations of Avivagen Inc. regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Avivagen Inc. assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements. The results of treatment described above are based on historical results. Different animals may experience different results from the treatments described in the video.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information:
David Hankinson Graham Burton, PhD
CEO, Avivagen Inc. President and Co-Founder, Avivagen Inc.
Phone: 902-825-9270 Phone: 613-990-0969
d.hankinson@chemaphor.com g.burton@chemaphor.com
Copyright (c) 2012 Thenewswire.ca - All rights reserved.

Source: TheNewsWire (May 29, 2012 - 6:00 AM EDT)

News by QuoteMedia